29 June 2026 - July is a bumper month for cheaper medicines with 10 new listings giving Australians expanded access to effective and affordable medicines on the PBS.
Tezepelumab (Tezspire) will be listed for the first time to treat patients aged 12 years and older whose severe uncontrolled asthma causes a buildup of white blood cells leading to inflammation and tissue damage (eosinophilia) or causes the immune system to overreact to allergens.